Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)
Clinical trial NCT00875056 · COMPLETED
Trial details
- NCT number
- NCT00875056
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-15
- Primary completion
- 2011-09-06
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.